LLY's stock drops despite Q2 earnings beat, as its oral obesity pill underwhelms with 12.4% weight loss in trial.

With safer design, more robust reasoning, expanded developer tooling, and broad user access, GPT-5 reflects a maturing AI ecosystem.

The new GPT-5 is supposed to program better and answer technical questions with fewer hallucinations. US companies are ...

Early August, 2025, 19 of the 30 Dow Index were tagged "safer" for dividends as they showed positive one-year returns and ...

Major indices delivered a mixed performance on Thursday after Donald Trump's newly announced chip tariffs included broad ...

With autonomy from its former parent, we think Sandoz can freely allocate resources to fit its best needs and grow the business. Sandoz is one of the largest biosimilars players in the world, and we ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Major indices were in the green early on Thursday after Donald Trump's newly announced chip tariffs included broad exemptions.

Eli Lilly stock tumbled Thursday on an unexpected setback for its obesity franchise, sending shares of its rival flying.